Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Jasper Therapeutics Inc JSPR

Healthcare Biotechnology
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapeutics targeting mast cell driven diseases, such as Chronic Spontaneous Urticaria (CSU) and Chronic Inducible Urticaria (CIndU). It also has ongoing programs in diseases where targeting diseased hemopoietic stem cells can provide benefits, such as Lower to Intermediate Risk... see more

Bullboard (NDAQ:JSPR)

View:
1 2 Next
Post by whytestockson Oct 14, 2024 10:15am

Jasper Therapeutics Reports Positive Data from SPOTLIGHT Stu

JUST IN: $JSPR Jasper Therapeutics Reports Positive Data from SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria14 of 15 participants enrolled achieved a clinical response 10 of 12 ...more  
27
Post by whytestockson Jun 14, 2024 3:30pm

Jasper Therapeutics Presents Data from Preclinical Briquilim

NEWS: $JSPR Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid CongressREDWOOD CITY, Calif., June 14, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc ...more  
44
Post by whytestockson Feb 07, 2024 4:45pm

Jasper Therapeutics to Present at the Oppenheimer 34th Annua

JUST IN: $JSPR Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Conference | BenzingaREDWOOD CITY, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ ...more  
58
Post by whytestockson Feb 07, 2024 4:30pm

Jasper Therapeutics to Present at the Oppenheimer 34th Annua

Just In: $JSPR Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare ConferenceREDWOOD CITY, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR ...more  
54
Post by whytestockson Feb 06, 2024 1:15pm

Jasper Therapeutics Announces Pricing of $50 Million Underwr

News; $JSPR Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common StockREDWOOD CITY, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) ( ...more  
45
Post by whytestockson Feb 05, 2024 2:30am

When (JSPR) Moves Investors should Listen

Breaking News: $JSPR When (JSPR) Moves Investors should Listen2024-02-05 01:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks ...more  
94
1 2 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities